Loading clinical trials...
Loading clinical trials...
The main study hypothesis is that Sjögren Disease (SD), usually considered a disorder typical of adult females, may occur not exceptionally in adolescence or even in childhood as a subclinical process...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
IRCCS Burlo Garofolo
NCT03003572 · Primary Sjögren's Syndrome
NCT07048197 · Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
NCT07361094 · Relapsed/Refractory Systemic Lupus Erythematosus, Relapsed/Refractory Systemic Sclerosis, and more
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT06440525 · Primary Sjögren Syndrome
Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
Trieste
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC)
Udine
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions